← Back to Search

Study Procedure (all participants) for Premenstrual Dysphoric Disorder (PHASE Project Trial)

N/A

Waitlist Available

Led By Ajna Hamidovic, PharmD, MS

Research Sponsored by University of Illinois at Chicago

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 2 hours

Awards & highlights

PHASE Project Trial Summary

This trial is designed to see if a certain medication can help with the symptoms of premenstrual syndrome.

PHASE Project Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ one menstrual cycle

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~one menstrual cycle

This trial's timeline: 3 weeks for screening, Varies for treatment, and one menstrual cycle for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Affect

Cardiovascular function

Estradiol concentrations at 6 menstrual cycle sub-phases

+1 more

PHASE Project Trial Design

1Treatment groups

Experimental Treatment

Group I: Study Procedure (all participants)Experimental Treatment1 Intervention

Diagnostic Phase (2 months): at-home urine hormone testing and completion of daily online surveys. Individualized Task (-6 to -2 days from the subsequent menstrual cycle)

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Individualized laboratory test

2019

N/A

~210

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of Illinois at ChicagoLead Sponsor

608 Previous Clinical Trials

1,559,298 Total Patients Enrolled

Ajna Hamidovic, PharmD, MSPrincipal Investigator - University of Illinois at Chicago

University of Illinois at Chicago

1 Previous Clinical Trials

4 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the cap on participant numbers for this clinical trial?

"Affirmative. The data hosted on clinicaltrials.gov indicates that this medical trial, which was first published in September 2019, is currently enrolling patients. One site needs to recruit 120 individuals for the study's completion."

Answered by AI

Does this research endeavor accept participants aged over 25?

"According to the study's requirements, only individuals within the age range of 18-35 are eligible for enrollment."

Answered by AI

May I become a participant in this clinical trial?

"This experiment is searching for 120 females between 18 and 35 years of age who suffer from premenstrual tension. To qualify, individuals must provide documentation that verifies their identity, be within the specified age range mentioned previously, and have a menstrual cycle ranging from 21-35 days in length."

Answered by AI

Are there any openings for participation in this study at the present time?

"Affirmative. On clinicaltrials.gov, it is confirmed that this experiment commenced recruiting on September 26th 2019 and was recently updated as of October 7th 2022. At the moment, 120 patients need to be admitted at one medical centre for the trial to proceed."

Answered by AI

Recent research and studies

European RadiologyJournal

Larger Volume and Different Functional Connectivity of the Amygdala in Women with Premenstrual Syndrome

Deng, Demao, Yong Pang, Gaoxiong Duan, Huimei Liu, Hai Liao, Peng Liu, Yanfei Liu, et al.. 2017. “Larger Volume and Different Functional Connectivity of the Amygdala in Women with Premenstrual Syndrome”. European Radiology. Springer Science and Business Media LLC. doi:10.1007/s00330-017-5206-0.

European Journal of Obstetrics & Gynecology and Reproductive BiologyJournal

Prevalence of Premenstrual Syndrome and Premenstrual Dysphoric Disorder in a Population-based Sample in China

Qiao, Mingqi, Huiyun Zhang, Huimin Liu, Songping Luo, Tianfang Wang, Junlong Zhang, and Lijin Ji. 2012. “Prevalence of Premenstrual Syndrome and Premenstrual Dysphoric Disorder in a Population-based Sample in China”. European Journal of Obstetrics & Gynecology and Reproductive Biology. Elsevier BV. doi:10.1016/j.ejogrb.2012.01.017.

PsychoneuroendocrinologyJournal

Sustained Attention Is Favored by Progesterone During Early Luteal Phase and Visuo-spatial Memory by Estrogens During Ovulatory Phase in Young Women

Solís-Ortiz, S., and M. Corsi-Cabrera. 2008. “Sustained Attention Is Favored by Progesterone During Early Luteal Phase and Visuo-spatial Memory by Estrogens During Ovulatory Phase in Young Women”. Psychoneuroendocrinology. Elsevier BV. doi:10.1016/j.psyneuen.2008.04.003.

Drug and Alcohol DependenceJournal